Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2018-11-08 Report Publication Anno…
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Datum:08.11.2018
Report Publication Announcement Classification · 100% confidence The document is a short notification (784 characters) informing stakeholders that the interim management report for the period 01.01.2018 to 30.09.2018 has been published and provides a link to the company's website to access it. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2018-11-08 German
aap Implantate AG adjusts outlook for financial year 2018
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' announcement dated November 2, 2018, disclosing an 'inside information' according to MAR Regulation (EU) No 596/2014. The core content is the adjustment of the sales and EBITDA forecast for the financial year 2018 due to lower-than-expected sales and one-time costs. This is a direct announcement of a change in financial outlook, which is a key component of an Earnings Release (ER) or a general financial update. Since it is specifically about adjusting the *outlook* (forecast) rather than releasing the final, audited results for a period (which would be 10-K or IR), and it contains preliminary figures for Q3/9M 2018, it aligns best with the function of an Earnings Release (ER) which often includes forward-looking statements and guidance changes. It is not a full report (10-K/IR) nor a transcript (CT). It is a direct financial performance update/profit warning. FY 2018
2018-11-02 English
aap receives funding for its innovative antibacterial silver coating technology
Capital/Financing Update Classification · 99% confidence The document is a news release titled "aap receives funding for its innovative antibacterial silver coating technology" and is disseminated via DGAP-News. It announces a specific corporate event: receiving a grant/funding from the German Federal Ministry of Education and Research (BMBF) for R&D related to a medical technology. This type of announcement, detailing financing, grants, or capital structure updates, aligns best with the 'Capital/Financing Update' category (CAP). It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific announcement about securing funding, CAP is the most appropriate classification.
2018-10-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement titled 'Total Voting Rights Announcement' from aap Implantate AG, dated September 28, 2018. It explicitly mentions compliance with Article 41 of the WpHG (German Securities Trading Act) regarding the publication of the total number of voting rights following a 'Conditional capital increase'. This type of announcement, which reports a change in the total number of shares/voting rights, fits best under the 'Share Issue/Capital Change' category (SHA). Although it is a regulatory filing distributed via DGAP, SHA is more specific than the general RNS fallback.
2018-09-28 English
aap Implantate AG: Double-digit Q2/2018 sales growth; sales and EBITDA at upper end of guidance
Earnings Release Classification · 100% confidence The document text explicitly states it contains 'Key word(s): Half Year Results' and provides detailed financial figures for 'Q2/2018' and 'H1/2018' (First Half). This structure, focusing on interim financial performance (six months), aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is a comprehensive report of results, not just a brief announcement of publication (RPA/RNS). H1 2018
2018-08-14 English
Halbjahresfinanzbericht
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresfinanzbericht 2018' (Half-Year Financial Report 2018) for aap Implantate AG. It contains comprehensive financial data, including income statements, cash flow, balance sheet items, and management commentary for the first half of the year. It is not a short announcement, but a full interim report containing substantive financial data, which fits the definition of an Interim/Quarterly Report (IR). H1 2018
2018-08-14 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.